A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
Clinical trial NCT02034006 · COMPLETED
Trial details
- NCT number
- NCT02034006
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-10
- Primary completion
- 2016-07-15
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.